Regenerative medicine: The emergence of an industry

Journal of the Royal Society Interface

Volumn 7, Issue SUPPL. 6, 2010, Pages

  Nerem, Robert M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell based technologies; Industry; Regenerative medicine; Tissue engineering

Indexed keywords

INDUSTRY; TISSUE;

CELL-BASED TECHNOLOGIES; FULL TIME EQUIVALENTS; MEDICAL DEVICES; PHARMACEUTICAL INDUSTRY; PRIVATE SECTORS; REGENERATIVE MEDICINE; TISSUE ENGINEERING INDUSTRY;

TISSUE ENGINEERING;

BIOTECHNOLOGY; HEALTH CARE INDUSTRY; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING;

EID: 78649886111     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2010.0348.focus     Document Type: Review

References (32)

1. Badylak, S. F. et al. 1999 Naturally occurring ECMs as scaffolds for musculoskeletal repair. Clin. Ortho. Relat. Res. 3675, 333-343.
2. Bell, E. et al. 1981 The reconstitution of living skin. Science 211, 1042-1054.
3. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O. & Peterson, I. 1994 Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New Engl. J. Med. 331, 889-895. (doi:10.1056/NEJM199410063311401)
4. Burke, J. F., Yannas, I. V. & Quinby Jr, W. C. 1981 Successful use of a physiologically acceptable artificial skin in the treatment of extensive bun injury. Ann. Surg. 194, 413-428. (doi:10.1097/00000658-198110000-00005)
5. Caplan, A. L. & Bruder, S. P. 2001 Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7, 259-264. (doi:10.1016/S1471-4914(01)02016-0)
6. Carrel, A. & Lindbergh, C. 1938 The culture of organs. New York, NY: Paul B. Hoeber, Inc., Harper Brothers.
7. Friedman, D. M. 2007 The immoralists. New York, NY: Harper Collins Publishers.
8. Gillian, M. 1999 Good Morning America, April 29.
9. Green, H. 1991 Cultured cells for treatment of disease. Sci. Am. 172, 64-70.
10. Langer, R. & Vacanti, J. P. 1993 Tissue engineering. Science 260, 920-925. (doi:10.1126/science.8493529)
11. Lindberg, K. & Badylak, S. 2001 Porcine small intestine submucosa (SIS): a bioscaffold supporting in vitro primary epidermal cell differentiation and syntheses of basement membrane proteins. Burns 27, 254-256. (doi:10.1016/S0305-4179(00)00113-3)
12. Lysaght, M. J. 1995 Product development in tissue engineering. Tissue Eng. 1, 221-228. (doi:10.1089/ten.1995.1.221)
13. Lysaght, M. J. & Reyes, J. 2001 The growth of tissue engineering. Tissue Eng. 7, 485-493. (doi:10.1089/107632701753213110)
14. Lysaght, M. J. & Hazlehurst, A. L. 2004 Tissue engineering: the end of the beginning. Tissue Eng. 10, 309-320. (doi:10.1089/107632704322791943)
15. Lysaght, M. J., Nguy, N. A. & Sullivan, K. 1998 An economic survey of the emerging tissue engineering industry. Tissue Eng. 4, 231-238. (doi:10.1089/ten.1998.4.231)
16. Lysaght, M. J., Jaklenec, A. & Deweerd, E. 2008 Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng. 14, 302-315. (Pubitemid 351972525)
17. Mason, C. & Manzotti, M. 2010 regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen. Med. 5, 307-313. (doi:10.2217/rme.10.37)
18. National Academies report. 2001 Stem cells and the future of regenerative medicine. Washington, DC: National Academic Press.
19. Naughton, G. 1999 Skin: the first tissue engineered products - the advanced tissue sciences story. Tissue Eng. 280, 84-85.
20. Naughton, G., Mansbridge, J. & Gentzkow, G. 1997 A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif. Organs 21, 1203-1210. (doi:10.1111/j.1525-1594.1997.tb00476.x)
21. Nerem, R. M. 2005 Tissue engineering: confronting the transplantation crisis: tissue engineering, stem cells, and gene therapies (ed. Y. M. Elcin), pp. 1-9. New York, NY: Kluwer Academic Plenum Publishers.
22. Nerem, R. M. & Sambanis, A. 1995 Tissue engineering: from biology to biological substitutes. Tissue Eng. 1, 3-13. (doi:10.1089/ten.1995.1.3)
23. Palmer, J. 2000. Spare body parts. Barron's May 15 Issue.
24. Parenteau, N. 1999 Skin: the first tissue-engineered products - the organogenesis story. Sci. Am. 280, 84-85.
25. Rheinwald, J. G. & Green, H. 1997 Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265, 421-424. (doi:10.1038/265421a0)
26. Shamblott, M. J. et al. 1998 Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl Acad. Sci. USA 95, 13 726-13 731. (doi:10.1073/pnas.95.23.13726)
27. Skalak, R. & Fox, C. 1988 NSF Workshop, UCLA Symp. Molecular and Cellular Biology, 1988. New York, NY: Alan R. Liss.
28. Thomson, J. A. et al. 1998 Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. (doi:10.1126/science.282.5391.1145)
29. Yamanaka, S. 2009 A fresh look at iPS cells. Cell 137, 13-17. (doi:10.1016/j.cell.2009.03.034)
30. Yannas, I. V. & Burke, J. F. 1980 Design of an artificial skin I: basic design principles. J. Biomed. Mater. Res. 14, 65-81. (doi:10.1002/jbm. 820140108)
31. Yannas, I. V. 1998 Studies on the biological activity of the dermal regeneration template. Wound Repair Regen. 6, 518-523. (doi:10.1046/j.1524-475X. 1998.60604.x)
32. Young, R. R. 2010 Stem cell summit executive summary. New York, NY: RRY Publications.